Showing results (161-170 of 184) with videos related to
Sort By:
Pageof 19
Biochimica Et Biophysica Acta|October 11, 2015
Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1Stefan A Ljunggren, Johannes H M Levels, Kees Hovingh, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2009
Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I productionRemco Franssen, Raaj R Sankatsing, Elly Hassink, et al.Pharmacogenetics|November 20, 2002
The effectiveness of hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) in the elderly is not influenced by apolipoprotein E genotypeAnke-Hilse Maitland-van der Zee, Bruno H Stricker, Olaf H Klungel, et al.Journal of Lipid Research|October 29, 2002
Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemiaAlan D Attie, Ronald M Krauss, Mark P Gray-Keller, et al.Lancet (London, England)|July 17, 2007
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trialMichiel L Bots, Frank L Visseren, Gregory W Evans, et al.Circulation|October 4, 2000
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study GroupJ J Kastelein, J W Jukema, A H Zwinderman, et al.Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humansS I van Leuven, R S Birjmohun, R Franssen, et al.Pharmacological Research|June 13, 2017
The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trialsSorin Ursoniu, Dimitri P Mikhailidis, Maria-Corina Serban, et al.Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.The American Journal of Cardiology|April 6, 1999
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosisM P de Maat, J W Jukema, S Ye, et al.Pageof 19